Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra D Pittman

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Biochemical and Biophysical Research Communications|May 24, 2011
Inhibition of the Unfolded Protein Response by metformin in renal proximal tubular epithelial cellsJimmy R Thériault, Helen J Palmer, Debra D Pittman
Mabs|October 28, 2010
Pharmacokinetics and lung distribution of a humanized anti-RAGE antibody in wild-type and RAGE-/- miceYulia Vugmeyster, David DeFranco, Debra D Pittman, et al.
Research and Practice in Thrombosis and Haemostasis|November 17, 2025
Marstacimab, an antitissue factor pathway inhibitor, combined with bypassing agents: effects on thrombin generation and in hemostatically normal ratsMarjorie A Peraza, Swapnil Rakhe, Susan Hurst, et al.
The AAPS Journal|April 13, 2019
Induction and Impact of Anti-Drug Responses Elicited by a Human Recombinant Coagulation Factor FXa<sup>I16L</sup> in Preclinical SpeciesChuenlei Parng, Michael Bolt, Debra D Pittman, et al.
Research and Practice in Thrombosis and Haemostasis|March 23, 2022
Hemostatic efficacy of marstacimab alone or in combination with bypassing agents in hemophilia plasmas and a mouse bleeding modelDebra D Pittman, Swapnil Rakhe, Sheryl R Bowley, et al.
International Journal of Medical Sciences|June 9, 2006
Comparison of osteogenic potentials of human rat BMP4 and BMP6 gene therapy using [E1-] and [E1-,E2b-] adenoviral vectorsHongwei Li, Jin Zhong Li, Debra D Pittman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 6, 2003
Rat strain differences in the ectopic osteogenic potential of recombinant human BMP adenovirusesJin Zhong Li, Hongwei Li, Brad Dunford, et al.
European Journal of Haematology|May 15, 2022
Validation of patient-reported vaso-occlusive crisis day as an endpoint in sickle cell disease studiesKarin S Coyne, Brooke M Currie, Michael Callaghan, et al.
Clinical and Translational Science|January 1, 2019
PF-04447943, a Phosphodiesterase 9A Inhibitor, in Stable Sickle Cell Disease Patients: A Phase Ib Randomized, Placebo-Controlled StudyRobert J Charnigo, David Beidler, Denis Rybin, et al.
Bone|August 16, 2003
A gene expression profile for endochondral bone formation: oligonucleotide microarrays establish novel connections between known genes and BMP-2-induced bone formation in mouse quadricepsBrian M Clancy, Joyce D Johnson, Andre Jean Lambert, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Biochemical and Biophysical Research Communications|May 24, 2011
Inhibition of the Unfolded Protein Response by metformin in renal proximal tubular epithelial cellsJimmy R Thériault, Helen J Palmer, Debra D Pittman
Mabs|October 28, 2010
Pharmacokinetics and lung distribution of a humanized anti-RAGE antibody in wild-type and RAGE-/- miceYulia Vugmeyster, David DeFranco, Debra D Pittman, et al.
Research and Practice in Thrombosis and Haemostasis|November 17, 2025
Marstacimab, an antitissue factor pathway inhibitor, combined with bypassing agents: effects on thrombin generation and in hemostatically normal ratsMarjorie A Peraza, Swapnil Rakhe, Susan Hurst, et al.
The AAPS Journal|April 13, 2019
Induction and Impact of Anti-Drug Responses Elicited by a Human Recombinant Coagulation Factor FXa<sup>I16L</sup> in Preclinical SpeciesChuenlei Parng, Michael Bolt, Debra D Pittman, et al.
Research and Practice in Thrombosis and Haemostasis|March 23, 2022
Hemostatic efficacy of marstacimab alone or in combination with bypassing agents in hemophilia plasmas and a mouse bleeding modelDebra D Pittman, Swapnil Rakhe, Sheryl R Bowley, et al.
International Journal of Medical Sciences|June 9, 2006
Comparison of osteogenic potentials of human rat BMP4 and BMP6 gene therapy using [E1-] and [E1-,E2b-] adenoviral vectorsHongwei Li, Jin Zhong Li, Debra D Pittman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 6, 2003
Rat strain differences in the ectopic osteogenic potential of recombinant human BMP adenovirusesJin Zhong Li, Hongwei Li, Brad Dunford, et al.
European Journal of Haematology|May 15, 2022
Validation of patient-reported vaso-occlusive crisis day as an endpoint in sickle cell disease studiesKarin S Coyne, Brooke M Currie, Michael Callaghan, et al.
Clinical and Translational Science|January 1, 2019
PF-04447943, a Phosphodiesterase 9A Inhibitor, in Stable Sickle Cell Disease Patients: A Phase Ib Randomized, Placebo-Controlled StudyRobert J Charnigo, David Beidler, Denis Rybin, et al.
Bone|August 16, 2003
A gene expression profile for endochondral bone formation: oligonucleotide microarrays establish novel connections between known genes and BMP-2-induced bone formation in mouse quadricepsBrian M Clancy, Joyce D Johnson, Andre Jean Lambert, et al.
Pageof 4